~~<i id='02421F6E6C'><strike id='02421F6E6C'><tt id='02421F6E6C'><pre id='02421F6E6C'></pre></tt></strike></i>~~

Home» leisure time» comprehensive

comprehensive

author：hotspot 2025-10-04 08:48:02 Page View：6

Senate health committee Chair Bernie Sanders — Sen. Berne Sanders (I-Vt.) Kevin Dietsch/Getty Images

WASHINGTON — Sen. Bernie Sanders (I-Vt.) has a new corporate target: the food industry.

Sanders held a hearing today on diabetes that implicated both the food and drug industries in what the American Diabetes Association estimates is a $413 billion annual cost to the health care system. That’s up 27% over the past six years, he said, and he warned that new weight loss drugs could send health care spending to the stratosphere.

But the food industry received more attention, especially from Sanders, than the drugmakers and drug middlemen.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Lasker Awards 2023: Winners in biomedical research
Next article： Heart attack and stroke risk calculators need revising

explore

After affirmative action ruling, medical educators look to 'holistic review'

AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

Biotech stock slump in 2023: awaiting the turnaround

AdobeThiswassupposedtobetheyearofthebiotechcomeback,whenpromisingnewmedicinesandhigh-dollarbuyoutswo

Supreme Court strikes down use of affirmative action

ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

Abortion pill Supreme Court ruling could impact entire drug industry

AnnaMoneymaker/GettyImagesWASHINGTON—TheSupremeCourtonTuesdaywillhearopeningargumentsinanabortionmed